Hot flushes at 3am, heavier or unpredictable periods, brain fog, anxiety and a sudden change in sleep can leave you asking one reasonable question: is this menopause? A menopause hormone testing guide can help you understand where laboratory testing adds useful detail, where symptoms matter more than a single result, and how to use your data well.
For many women, perimenopause begins while periods are still arriving. Hormones can fluctuate significantly from one week to the next, so testing is not always a simple yes-or-no answer. The value lies in choosing the right markers, collecting at the right time and interpreting results in the context of your age, cycle pattern, medication and symptoms.
When hormone testing is useful in menopause
In the UK, menopause is often identified clinically in women over 45 who have typical symptoms and changing periods. A laboratory test is not always required to confirm what an experienced clinician can establish from that history.
That does not mean testing has no place. It can be particularly useful when symptoms are complex, the picture is unclear, periods have stopped early, or you want a more detailed view of hormone patterns alongside related factors such as stress physiology, thyroid function or cardiometabolic health.
Testing may be worth considering if you are aged 40 to 45 with symptoms suggestive of menopause, if you are under 40 and have missed periods or symptoms that could indicate premature ovarian insufficiency, or if your symptoms overlap with another possible cause. Thyroid disorders, iron deficiency, poor sleep, high stress, medication effects and blood glucose dysregulation can all contribute to fatigue, palpitations, low mood and cognitive changes.
A comprehensive profile can also be useful for women who want measurable baseline data before discussing treatment options. It should support clinical decision-making, not replace it.
Which hormones matter most?
Oestradiol and progesterone
Oestradiol is the main form of oestrogen produced during the reproductive years. In perimenopause, it does not simply decline in a straight line. It can rise, fall and vary substantially across cycles. This variability helps explain why symptoms can change quickly, from breast tenderness and heavy bleeding one month to hot flushes and disrupted sleep the next.
Progesterone commonly becomes less predictable as ovulation becomes irregular. Lower progesterone exposure may be associated with shorter cycles, altered bleeding patterns, poor sleep or premenstrual-type symptoms, although a test result alone cannot establish the cause. The timing of a sample is particularly important when interpreting progesterone in someone who still menstruates.
FSH and LH
Follicle-stimulating hormone, or FSH, rises when the ovaries become less responsive to hormonal signalling. It can provide useful evidence of changing ovarian function, especially in women under 45. However, one normal FSH result does not rule out perimenopause, and one raised result does not tell the whole story. Levels can vary between cycles.
Luteinising hormone, or LH, may be included alongside FSH to provide further context on pituitary signalling. These markers are best interpreted as part of a wider pattern rather than treated as a standalone menopause score.
Testosterone and DHEA-S
Testosterone is not only relevant to men. Women produce it too, and levels may influence libido, motivation, muscle maintenance and energy. DHEA-S is produced mainly by the adrenal glands and can offer an indication of adrenal androgen production.
Low levels do not automatically explain low desire or fatigue, and replacement is not appropriate for everyone. Yet measuring these hormones can be valuable when symptoms persist despite addressing sleep, stress, thyroid health and oestrogen-related changes.
Cortisol and thyroid markers
Night sweats and anxiety can be menopausal symptoms, but cortisol rhythm, thyroid function and lifestyle pressures can complicate the picture. A broader assessment may be appropriate when symptoms include marked fatigue, waking unrefreshed, poor stress tolerance, weight changes, bowel changes or persistent palpitations.
Thyroid testing is especially relevant because an underactive or overactive thyroid can resemble menopause. A clinically useful assessment may include thyroid-stimulating hormone, free T4 and, where appropriate, free T3 and thyroid antibodies. The right panel depends on your symptoms and medical history.
Menopause hormone testing guide: choosing the right format
The specimen format should match the question you are trying to answer. Blood testing is commonly used for FSH, LH, oestradiol, thyroid markers and cardiometabolic measures. It offers a useful snapshot of circulating hormone levels at the point of collection.
Saliva testing can be used for selected steroid hormones and is convenient to collect at home. Dried urine testing can provide a broader view of hormone metabolites and daily cortisol patterns, which may be useful for women seeking deeper insight into hormone processing and adrenal rhythm. These formats are not interchangeable, so reference ranges and interpretation must be specific to the method used.
At Hormone Lab UK, home collection kits are analysed by specialist laboratories using clinically oriented methods, allowing you to access detailed hormone data without arranging a traditional clinic appointment. The best choice is not necessarily the largest panel. It is the panel that answers your most relevant question and provides results you can act on with a qualified professional.
How to prepare for more meaningful results
If you are still having periods, follow the collection timing instructions carefully. Some hormones are most informative at a particular stage of the cycle, while other tests may require multiple samples across the day. Record the first day of your last period, the usual length of your cycle and any unusual bleeding. This context matters when results are reviewed.
Be open about all medicines and supplements. Hormonal contraception, hormone replacement therapy (HRT), testosterone, progesterone, steroid medication and some supplements can alter results. FSH testing is generally not useful for confirming menopause while taking combined hormonal contraception or high-dose progestogen, because these treatments can suppress the hormone signals being measured.
Do not stop prescribed medication simply to test unless your prescriber has advised you to do so. Testing while on HRT can still offer selected information, but results must be interpreted with care. A laboratory value should not be used alone to increase, reduce or discontinue HRT.
It also helps to keep a concise symptom record for two to four weeks. Note hot flushes, sleep quality, mood, energy, libido, headaches, cycle changes and any triggers. A result becomes far more useful when it can be matched to a clear symptom pattern.
Understanding the limits of a single test
Hormones are dynamic. Perimenopause is defined by fluctuation, so a single sample cannot capture every change occurring across a month or a year. A result in range does not mean your symptoms are imagined, and a result outside a reference range does not automatically identify the best treatment.
Reference ranges also need careful handling. A range describes values observed in a reference population; it is not a guarantee of wellbeing. Your age, menstrual status, use of hormones, collection time and the laboratory method all affect interpretation.
This is why specialist interpretation is valuable for more advanced profiles. It can help distinguish a pattern that warrants a conversation about menopause support from one that suggests checking thyroid health, iron status, glucose regulation, medication effects or another clinical issue.
When to speak to a clinician promptly
Seek medical advice promptly for very heavy bleeding, bleeding after sex, bleeding after menopause, severe pelvic pain, sudden chest pain, shortness of breath, fainting or new neurological symptoms. These concerns should not be attributed to menopause without assessment.
If periods stop before age 45, particularly before 40, arrange a clinical review. Early menopause and premature ovarian insufficiency can have implications for bone, heart and long-term health, and deserve timely medical support.
A well-chosen test can turn vague symptoms into a clearer clinical conversation. Use the information to ask better questions, track meaningful changes and make decisions with the right professional support behind you.